Q2 2024 Holdings
Filed 2024-08-14 | 26 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Natera Inc(NTRA) | COM | 632307104 | $218.1M | 2,014,408 | 16.8% |
| Vertex Pharmaceuticals Inc(VRTX)Put | COM | 92532F100 | $154.7M | 330,000 | 11.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $125.4M | 3,388,967 | 9.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $117.5M | 5,722,057 | 9.1% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $109.1M | 200,000 | 8.4% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $79.5M | 7,082,562 | 6.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $78.1M | 9,260,385 | 6.0% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $67.0M | 1,000,000 | 5.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $56.9M | 753,240 | 4.4% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $55.8M | 1,543,669 | 4.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $54.5M | 8,826,710 | 4.2% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $27.7M | 800,000 | 2.1% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $22.9M | 5,953,825 | 1.8% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $22.8M | 1,750,000 | 1.8% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $19.8M | 3,975,521 | 1.5% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $16.6M | 2,021,659 | 1.3% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $11.0M | 916,574 | 0.8% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $10.7M | 1,641,891 | 0.8% |
| Alnylam Pharmaceuticals Inc(ALNY)Put | COM | 02043Q107 | $10.4M | 43,000 | 0.8% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $9.1M | 566,715 | 0.7% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $8.4M | 12,155,830 | 0.6% |
| Burning Rock Biotech LTD(BNR) | SPONSORED ADS | 12233L206 | $6.3M | 974,668 | 0.5% |
| Sutro Biopharma Inc | COM | 869367102 | $5.9M | 2,023,683 | 0.5% |
| Acelyrin Inc | COM | 00445A100 | $3.7M | 831,310 | 0.3% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $2.7M | 1,646,702 | 0.2% |
| CG Oncology Inc(CGON) | COM | 156944100 | $1.7M | 53,911 | 0.1% |